EUVIMEDOdkrijte EUVIMED
CrossrefInformacijska kartica

Histiocytosis X or Langerhans’ Cell Histiocytosis – Evaluation, Treatment and Prognosis

I. Haas, A. Donner

Oto-Rhino-Laryngologia Nova · 1998

DOI: 10.1159/000027814 ↗
PovzetekBibliografski podatki

Povzetek

Objectives: The pathology and the extreme clinical varieties of this disease with emphasis on head and neck manifestations are discussed. Material: A case of Langerhans’ cell histiocytosis (LCH) with extensive destruction of temporal bones is presented. Results and Conclusions: LCH or histiocytosis X embraces a group of rare, mainly pediatric disorders of disputable nature. Granulomatous lesions can be detected in one (unifocal) or multiple organs or tissues (multifocal) with extreme clinical variety from self-healing monostotic lesions to multisystemic life-threatening disease. Lesions typically consist of dendritic antigen-presenting Langerhans’ cells, eosinophilic granulocytes, lymphocytes, ordinary histiocytes, foam cells and multinucleated giant cells. No histopathologic criteria exist in regard to prognosis. Unpredictable behavior of LCH also defies a convenient clinical classification, but number of lesions, vital organ involvement and dysfunction seem to be prognostically and thus therapeutically relevant. Although proof of monoclonality indicates a true neoplastic process, no prognostic use results so far since clonality has been detected in all forms of LCH.

Znanje, ki ustreza vašemu delu.

Od brezplačnega začetka in osebnega iskanja literature do celotnega paketa Research Suite.

Ogled tarif →

Ali so vključena vsa polna besedila založnikov?

Ne. Bibliografski zapisi, povzetki in celotna besedila so različne vsebine. Ali je celotno besedilo na voljo, je odvisno od vira, odprtega dostopa in vaših obstoječih licenc. Paket EUVIMED ne nadomešča dodatnih pravic založnikov.

Ogled tarif →